SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000930413-12-003523
Filing Date
2012-06-11
Accepted
2012-06-11 16:27:00
Documents
11
Period of Report
2012-04-30

Document Format Files

Seq Description Document Type Size
1 c69924_10-q.htm 10-Q 729984
2 c69924_ex31-1.htm EX-31.1 9265
3 c69924_ex31-2.htm EX-31.2 9625
4 c69924_ex32-1.htm EX-32.1 3267
5 c69924_ex32-2.htm EX-32.2 3475
  Complete submission text file 0000930413-12-003523.txt   4369024

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE enz-20120430.xml EX-101.INS 994883
7 enz-20120430.xsd EX-101.SCH 19317
8 XBRL CALCULATION FILE enz-20120430_cal.xml EX-101.CAL 34265
9 XBRL DEFINITION FILE enz-20120430_def.xml EX-101.DEF 98779
10 XBRL LABEL FILE enz-20120430_lab.xml EX-101.LAB 131348
11 XBRL PRESENTATION FILE enz-20120430_pre.xml EX-101.PRE 101717
Mailing Address ENZO BIOCHEM INC 60 EXECUTIVE BLVD FARMINGDALE NY 11735
Business Address 60 EXECUTIVE BLVD FARMINGDALE NY 11735 5167555500
ENZO BIOCHEM INC (Filer) CIK: 0000316253 (see all company filings)

IRS No.: 132866202 | State of Incorp.: NY | Fiscal Year End: 0731
Type: 10-Q | Act: 34 | File No.: 001-09974 | Film No.: 12900790
SIC: 8071 Services-Medical Laboratories